Cargando…

Multi‐centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers

Diabetic foot ulcers (DFUs) pose a significant risk for infection and limb loss. Advanced wound therapies including human skin allografts have shown promise in resolving these challenging wounds. The primary objective of this randomised, prospective study was to compare the response of 100 subjects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, David G., Galiano, Robert D., Orgill, Dennis P., Glat, Paul M., Carter, Marissa J., Di Domenico, Lawrence A., Reyzelman, Alexander M., Zelen, Charles M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013597/ https://www.ncbi.nlm.nih.gov/pubmed/35080127 http://dx.doi.org/10.1111/iwj.13759

Ejemplares similares

A Prospective Multicenter Study of a Weekly Application Regimen of Viable Human Amnion Membrane Allograft in the Management of Nonhealing Diabetic Foot Ulcers
por: Galiano, Robert D., et al.
Publicado: (2023)

A multi‐centre, single‐blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers
por: Armstrong, David G., et al.
Publicado: (2021)

A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis
por: Armstrong, David G., et al.
Publicado: (2021)

Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi‐centre clinical trial with a microvascular tissue allograft
por: Gould, Lisa J., et al.
Publicado: (2021)

Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi‐centre clinical trial
por: Armstrong, David G., et al.
Publicado: (2022)

An observational pilot study using a purified reconstituted bilayer matrix to treat non‐healing diabetic foot ulcers
por: Armstrong, David G., et al.
Publicado: (2020)

Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open‐label, single‐arm feasibility study in diabetic foot ulcers
por: Armstrong, David G., et al.
Publicado: (2020)

Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations
por: Glat, Paul, et al.
Publicado: (2019)

Open-label Venous Leg Ulcer Pilot Study Using a Novel Autolologous Homologous Skin Construct
por: Armstrong, David G., et al.
Publicado: (2020)

A single arm prospective feasibility study evaluating wound closure with a unique wearable device that provides intermittent plantar compression and offloading in the treatment of non‐healing diabetic foot ulcers
por: Armstrong, David G., et al.
Publicado: (2022)

A multicenter, randomized controlled clinical trial evaluating the effects of a novel autologous heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Final analysis
por: Armstrong, David G., et al.
Publicado: (2023)

A Multicenter, Randomized, Controlled, Clinical Trial Evaluating Dehydrated Human Amniotic Membrane in the Treatment of Venous Leg Ulcers
por: Serena, Thomas E., et al.
Publicado: (2022)

Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial
por: DiDomenico, Lawrence A., et al.
Publicado: (2016)

Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi‐centre clinical trial in 80 patients
por: DiDomenico, Lawrence A, et al.
Publicado: (2018)

A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers
por: Zelen, Charles M, et al.
Publicado: (2016)

An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow‐up trial
por: Zelen, Charles M, et al.
Publicado: (2018)

Functional Properties of a Purified Reconstituted Bilayer Matrix Design Support Natural Wound Healing Activities
por: Armstrong, David G., et al.
Publicado: (2021)

Matched‐cohort study comparing bioactive human split‐thickness skin allograft plus standard of care to standard of care alone in the treatment of diabetic ulcers: A retrospective analysis across 470 institutions
por: Barbul, Adrian, et al.
Publicado: (2019)

A prospective, randomised, controlled, multi‐centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers
por: Zelen, Charles M, et al.
Publicado: (2014)

A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers
por: Zelen, Charles M, et al.
Publicado: (2014)

The Use of Split-Thickness Skin Grafts on Diabetic Foot Ulcerations: A Literature Review
por: McCartan, Brant, et al.
Publicado: (2012)

Wound repair, safety, and functional outcomes in reconstructive lower extremity foot and ankle surgery using a dehydrated amnion/chorion allograft membrane
por: Tacktill, Jordan Z., et al.
Publicado: (2022)

Human Split-Thickness Skin Allograft: Skin Substitute in the Treatment of Burn
por: Mahdavi-Mazdeh, M., et al.
Publicado: (2013)

A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics
por: Tettelbach, William, et al.
Publicado: (2018)

Autologous Minimally Manipulated Homologous Adipose Tissue (AMHAT) for Treatment of Nonhealing Diabetic Foot Ulcers
por: Armstrong, David G., et al.
Publicado: (2022)

Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi‐centre comparative study examining clinical efficacy and cost
por: Zelen, Charles M, et al.
Publicado: (2015)

Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers
por: Walters, Jodi, et al.
Publicado: (2016)

Human Split-Thickness Skin Allograft from Brain-Dead Donors
por: Khodadadi, A., et al.
Publicado: (2016)

A Prospective Study of Negative Pressure Wound Therapy With Integrated Irrigation for the Treatment of Diabetic Foot Ulcers
por: Zelen, Charles M., et al.
Publicado: (2011)

Split thickness skin grafts for the treatment of non-healing foot and leg ulcers in patients with diabetes: a retrospective review
por: Anderson, John J., et al.
Publicado: (2012)

A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix(®)) allograft for the treatment of venous leg ulcers
por: Bianchi, Christian, et al.
Publicado: (2017)

A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers
por: Zelen, Charles M, et al.
Publicado: (2013)

Degloved foot sole successfully reconstructed with split thickness skin grafts
por: Janssens, Loes, et al.
Publicado: (2014)

Acute Marjolin's Ulcer Arising in a Split-Thickness Skin Graft Postburn Injury
por: Moonsamy, Philicia, et al.
Publicado: (2016)

A Novel Reticular Dermal Graft Leverages Architectural and Biological Properties to Support Wound Repair
por: Dasgupta, Anouska, et al.
Publicado: (2016)

Large wound surgery of diabetic foot ulcer with Split-thickness skin graft (STSG), and maggot debridement therapy (MDT): A case report
por: Rahimi, Kamal, et al.
Publicado: (2023)

A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
por: Fang, Robert C, et al.
Publicado: (2008)

Systematic review on the rational use of amniotic membrane allografts in diabetic foot ulcer treatment
por: Lakmal, Kasun, et al.
Publicado: (2021)

Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers
por: Da Silva, Jessica, et al.
Publicado: (2021)

Gamma-treated placental amniotic membrane allograft as the adjuvant treatment of unresponsive diabetic ulcer of the foot
por: Oesman, Ihsan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ggqkontpdr3pqoo9sc5n969veo